More importantly, it was also demonstrated that cells completely deficient in TSG101 (i.e., genomic knockout) exhibited a significant reduction in EGFR and ERBB2 [38], and, as discussed later, there is no experimental evidence to date that would suggest that deficiency in TSG101 is sufficient to cause neoplastic transformation and cancer [7,14,15,39]. Here, TSG101 is linked to cancer.